Minimum spanning tree analysis in advanced ovarian carcinoma: An investigation of sampling methods, reproducibility and correlation with histologic grade

Analytical and Quantitative Cytology and Histology

Volumn 19, Issue 3, 1997, Pages 194-201

  Brinkhuis, Mariël ^a   Meijer, Gerrit A ^a   Van Diest, Paul J ^a   Schuurmans, Leonard T ^a   Baak, Jan P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

minimum spanning tree; Ovarian neoplasms; Reproducibility of results

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER GRADING; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; REPRODUCIBILITY; SAMPLING; STATISTICAL ANALYSIS;

CELL DIFFERENTIATION; DISCRIMINANT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SAMPLING STUDIES;

EID: 0030986257     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Baak JPA: Possibilities and progress of quantitative pathological examination of ovarian tumors. Eur J Obstet Gynecol Reprod Biol 1988;29:183-189
2. Baak JPA, Chan KK, Stolk JG, Kenemans P: Prognostic factors in borderline and invasive ovarian tumors of the common epithelial type. Pathol Res Pract 1987;182:755-774
3. Baak JPA, Langley FA, Talerman A, Delemarre JFM: Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing. Analyt Quant Cytol Histol 1986; 8:354-357
4. Baak JPA, Langley FA, Talerman A, Delemarre JFM: Prognostic variability of ovarian tumor grading by different pathologists. Gynecol Oncol 1987;27:166-172
5. Baak JPA, Schipper NW, Wisse-Brekelmans ECM, Ceelen TH, Bosman FT, van Geuns H, Wils J: The prognostic value of morphometrical features and cellular DNA content in cisplatin treated late ovarian cancer patients. Br J Cancer 1988; 57:503-508
6. Baak JPA, Wisse-Brekelmans ECM, Langley FA, Talerman A, Delemarre JFM: Morphometric data to FIGO stage and histological type and stage for prognosis in ovarian tumors. J Clin Pathol 1986;39:1340-1346
7. Bertelsen K, Hølund B, Andersen E: Reproducibility and prognostic value of histologic type and grade in early ovarian cancer. Int J Gynecol Cancer 1993;3:72-79
8. Bibbo M, Kim DH, di Loretto C, Dytch HE, Galera-Davidson H, Thompson D, Richards DL, Bartels HG, Bartels PH: Tissue architectural features for the grading of prostatic carcinoma. Analyt Quant Cytol Histol 1990;12:229-236
9. Bibbo M, Kim DH, Pfeifer T, Dytch HE, Galera-Davidson H, Bartels PH: Histometric features for the grading of prostatic carcinoma. Analyt Quant Cytol Histol 1991;13:61-68
10. Broders AC: Carcinoma: Grading and practical application. Arch Pathol 1926;2:376-381
11. Brugghe J, Baak JPA, Wiltshaw E, Fisher C: Further evaluation of reproducibility and prognostic value of histologic typing and grading in FIGO I ovarian cancer patients without systemic treatment. Int J Gynecol Cancer 1995;5:262-268
12. Buist MR, Kenemans P, den Hollander W, Vermorken JB, Molthoff CJM, Burger CW, Heimerhorst TJM, Baak JPA, Roos JC: Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab′)2 fragments in ovarian carcinoma patients. Cancer Res 1993;53: 5413-5418
13. Carey MS, Dembo AJ, Simm JE, Fyles AW, Treger T, Bush RS: Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: A 15-year review. Int J Gynecol Cancer 1993;3:24-35
14. Czernobilsky B: Common epithelial tumors of the ovary. In Blaustein's Pathology of the Female Genital Tract. Edited by RJ Kurman. New York, Springer-Verlag, 1987, pp 560-607
15. van Diest PJ, Baak JPA, Brugghe J, van de Burg MEL, van Oosterom AT, Neijt JP: Quantitative pathologic features as predictors of long term survival in patients with advanced ovarian cancer treated with cisplatin. Int J Gynecol Cancer 1994;4:174-180
16. van Diest PJ, Fleege JC, Baak JPA: Syntactic structure analysis in breast cancer: Analysis of reproducibility, biologic background and prognostic value. Hum Pathol 1992;23:876-883
17. Dussert C, Kopp F, Gandilhon P, Porreau-Schneider N, Rasigni M, Palmari J, Rasigni G, Martin PM, Llebaria A: Toward a new approach in tumor cell heterogeneity using the concept of order. Analyt Cell Pathol 1989;1:123-132
18. Dussert C, Rasigni M, Palmari J, Rasigni G, Llebaria A, Marry F: Minimal spanning tree analysis of biological structures. J Theor Biol 1987;125:317-323
19. Fleege JC, van Diest PJ, Baak JPA: Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest 1990;63: 270-275
20. Fleege JC, van Diest PJ, Baak JPA: Refinement and multi-observer evaluation of systematic random sampling to improve reproducibility in interactive nuclear morphometry. Analyt Quant Cytol Histol 1993;15:281-289
21. Friedlander ML, Dembo AJ: Prognostic factors in ovarian cancer. Semin Oncol 1991;18:205-212
22. Haapasalo H, Atkin NB, Collan Y, Pesonen E, Paljärvi L: Tumor ploidy, morphometry, histological and clinical features in ovarian carcinoma: Mutual relations. Analyt Cell Pathol 1991;3:261-271
23. Haapasalo H, Collan Y, Atkin NB, Pesonen E, Seppä A: Prognosis of ovarian carcinomas: Prediction by histoquantitative methods. Histopathology 1989;15:167-178
24. Haapasalo H, Collan Y, Montironi R, Pesonen E, Atkin NB: Consistency of quantitative methods in ovarian tumor histopathology. Int J Gynecol Pathol 1990;9:208-216
25. Haapasalo H, Collan Y, Seppä A, Gidlund A-L, Atkin NB, Pesonen E: Prognostic value of ovarian grading methods: A method comparison study. Histopathology 1990;16:1-7
26. Hernandez E, Bhagavan BS, Parmley TH, Rosenshein NB: Interobserver variability in the interpretation of epithelial ovarian cancer. Gynecol Oncol 1984;17:117-123
27. Hoffman R, Jain AK: A test of randomness based on the minimal spanning tree. Pattern Rec Lett 1983;1:175-180
28. Houwelingen JC, ten Bokkel Huinink WW, van der Burg MEL, van Oosterom AT, Neijt JP: Predictability of the survival of patients with advanced ovarian cancer. J Clin Oncol 1989;7:769-773
29. Kayser K: Syntaktische Strukturanalyse in der Histopathologie. In Morphometrie in der Klinischen Pathologie. Edited by G Burger, M Oberholzer. Heidelberg, Springer-Verlag, 1989, pp 164-178
30. Kayser K, Bosslet K, Ebert W, Kiefer B: Differential diagnosis of mesothelioma and metastatic adenocarcinoma of pleura by means of indirect immunoperoxidase technique combined with syntactic structure analysis. Tum Diagn Ther 1987;8:28-35
31. Kayser K, Kiefer B, Toomes H, Burkhard HU: Analysis of adenomatous structures in histopathology. Analyt Quant Cytol Histol 1987;9:273-278
32. Kayser K, Shaver M, Modlinger F, Postl K, Moyers JJ: Neighbourhood analysis of low magnification structures (glands) in healthy, adenomatous, and carcinomatous colon mucosa. Pathol Res Pract 1986;181:153-158
33. Ludescher C, Weger AR, Lindholm J, Oefner D, Hausmaninger H, Reitsamer R, Mikuz G: Prognostic significance of tumor cell morphometry, histopathology and clinical parameters in advanced carcinoma. Int J Gynecol Pathol 1990; 9:343-351
34. Lund B, Williamson P, van Houwelingen HC, Neijt JP: Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma. Cancer Res 1990;50:4626-4629
35. Meijer GA, van Diest PJ, Baak JPA, Beentjes M: Boundary effects in syntactic structure analysis: Influence on minimal spanning tree features (abstr). Proc of the 8th International Symposium on Diagnostic Quantitative Pathology, Amsterdam, September 14-16, 1994
36. Meijer GA, van Diest PJ, Fleege JC, Baak JPA: Syntactic structure analysis of the arrangement of nuclei in dysplastic epithelium of colorectal adenomatous polyps. Analyt Quant Cytol Histol 1992;14:491-498
37. Mogensen O, Sørensen FB, Bichel P, Jakobsen A: Nuclear volume and prognosis in ovarian cancer. Int J Gynecol Cancer 1992;2:141-146
38. Neijt JP, ten Bokkel Huinink WW, van der Burg MEL, van Oosterom AT, Willemse PHB, Vermorken JB, van Lindert ACM, Heintz APM, Aartsen E, van Lent M, Trimbos JB, de Meijer AJ: Long-term survival in ovarian cancer. Eur J Cancer 1991;27:1367-1372
39. O'Callaghan JF: An alternative definition for "neighbourhood of a point." IEEE Trans Comput 1975;24:1121-1125
40. Ozols RF, Garvin AJ, Costa J, Simon RM, Young RC: Advanced ovarian cancer: Correlation of grade with response to therapy and survival. Cancer 1980;45:572-581
41. Pfisterer J, Kommoss F, Sauerbrei W, Renz H, du Bois A, Kiechle-Schwarz M, Pfeiderer A: Cellular DNA content and survival in advanced ovarian carcinoma. Cancer 1994;74: 2509-2515
42. Rodenburg CJ, Cornelisse CJ, Hermans J, Fleuren GJ: DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: A step forward in predicting the clinical outcome. Gynecol Oncol 1988;29:176-187
43. Russell P: The pathological assessment of ovarian neoplasms: III. The malignant "epithelial" tumors. Pathology 1979;11:493-532
44. Sorbe B, Frankendal B, Veress B: Importance of histologic grading in the prognosis of epithelial ovarian carcinoma. Obstet Gynecol 1982;59:576-582
45. Tezuka F, Higashiiwai H, Namiki T: Quantitative analysis of nuclear distribution pattern differentiating carcinoma from hyperplasia in endometrial cytologic studies. Am J Clin Pathol 1991;96:648-653
46. Tezuka F, Sato I, Higashiiwai H, Endo N, Ito K, Kasai M: Method for the quantitative evaluation of the distribution pattern of nuclei in normal and malignant endometrial epithelia. Analyt Quant Cytol Histol 1990;12:237-241
47. Visser O, Coebergh JWW, Schouten LJ (editors): Incidence of Cancer in the Netherlands, 1990: Second Report of the Netherlands Cancer Registry. Utrecht, Netherlands Cancer Registry, 1993
48. Weger AR, Ludescher C, Mikuz G, Kemmler G, Reitsamer R, Hausmaninger H, Lindholm J: The value of prognostic indicators in advanced ovarian cancer. Pathol Res Pract 1989;185: 676-679